Potassium Supplements
Kelas obat: Agen Antineoplastik
Panganggone Potassium Supplements
Hipokalemia
Pengobatan utawa pencegahan hipokalemia (kekurangan kalium) ing pasien sing diet ora cukup.
Kahanan sing bisa nuduhake utawa nyebabake kekurangan kalium kalebu muntah, diare, drainase cairan GI, hyperadrenalism, malnutrisi, debilitation, imbangan nitrogen negatif sing berpanjangan, alimentasi parenteral sing berpanjangan tanpa tambahan kalium, dialisis, alkalosis metabolik, asidosis metabolik utawa diabetes, kelainan saluran GI sing nyebabake penyerapan sing kurang, penyakit ginjel tartamtu, lan periodik familial. kelumpuhan sing ditondoi dening hipokalemia.
Kalium kudu kalebu ing regimen penggantian elektrolit jangka panjang lan wis dianjurake kanggo administrasi profilaksis rutin sawise operasi sawise aliran urin sing cukup.
Penggantian kalium bisa uga dituduhake ing pasien sing nampa obat-obatan tartamtu sing kadhangkala bisa nyebabake kekurangan kalium (contone, diuretik thiazide, inhibitor anhidrase karbonat, diuretik loop, sawetara kortikosteroid, kortikotropin, asam aminosalicylic, amphotericin B). Sanajan konsumsi panganan sing sugih kalium lan / utawa nggunakake pengganti uyah sing ngemot kalium bisa nyegah kekurangan kalium ing pasien sing nampa obat sing nyuda kalium, administrasi prophylactic kalium sing wicaksana bisa disaranake ing pasien sing dipilih sajrone terapi diuretik utawa kortikosteroid sing dawa, utamane yen dheweke didigitalisasi.
Kalium klorida biasane dadi uyah pilihan kanggo ngobati penipisan kalium, amarga ion klorida dibutuhake kanggo mbenerake hipokloremia sing asring diiringi kekurangan kalium lan amarga sitrat, bikarbonat, glukonat, utawa liyane. uyah kalium alkalinizing bisa nyebabake hipokloremia, utamane yen digunakake bebarengan karo diet sing diwatesi klorida.
Uyah kalium alkalinisasi (asetat, bikarbonat, sitrat, glukonat) kudu digunakake kanggo perawatan hipokalemia ing pasien karo asidosis metabolik. (contone, asidosis tubulus ginjal).
Kalium uga kasedhiya minangka uyah kalium fosfat; nanging, kalium fosfat biasane digunakake kanggo ngganti mundhut fosfat utawa mbenerake hipokalemia lan hypophosphatemia sing ana bebarengan.
Hipertensi
Asupan kalium sing ora nyukupi nduweni peran penting ing perkembangan hipertensi, lan asupan kalium diet sing dhuwur (kalebu nggunakake suplemen kalium) bisa nglindhungi saka perkembangan tekanan darah tinggi lan nambah. kontrol tekanan getih ing pasien hipertensi.
Umume ahli nyaranake nambah asupan kalium (3,5-5 g saben dina) ing pasien hipertensi minangka bagéan saka modifikasi gaya urip kajaba dikontraindikasi dening penyakit ginjel kronis (CKD) utawa nggunakake obat sing nyuda ekskresi kalium. (Waca Ati-ati: Pancegahan lan Kontraindikasi.) Tambah asupan kalium dianjurake utamane kanggo wong sing ora bisa nyuda asupan sodium kanthi cukup.
Asupan kalium sing nyukupi kudu dianggep minangka sarana kanggo nyegah pangembangan hipertensi. Sumber panganan sing akeh kalium kayata woh-wohan lan sayuran luwih disenengi tinimbang suplemen kalium.
Aritmia
Uyah kalium bisa digunakake kanthi ati-ati kanggo ngilangi aritmia keracunan glikosida jantung sing disebabake dening mundhut kalium.
Peningkatan konsentrasi kalium plasma kanthi 0,5–1,5 mEq/L utawa kanggo ULN bisa uga migunani kanggo ngatur tachyarrhythmia sawise operasi jantung, nanging strategi iki ora bisa digunakake ing pasien karo blok atrioventricular amarga kalium bisa luwih ngrusak konduksi nodal.
Toksisitas Thallium
Suplemen kalium IV, biasane kalium klorida, wis digunakake ing manajemen keracunan thallium† [off-label] kanggo ningkatake diuresis lan mobilisasi thallium saka jaringan; perawatan kasebut diwatesi dening jumlah thallium sing bisa dibebasake menyang getih tanpa gejala serebral sing luwih elek.
Related obat
- Abemaciclib (Systemic)
- Acyclovir (Systemic)
- Adenovirus Vaccine
- Aldomet
- Aluminum Acetate
- Aluminum Chloride (Topical)
- Ambien
- Ambien CR
- Aminosalicylic Acid
- Anacaulase
- Anacaulase
- Anifrolumab (Systemic)
- Antacids
- Anthrax Immune Globulin IV (Human)
- Antihemophilic Factor (Recombinant), Fc fusion protein (Systemic)
- Antihemophilic Factor (recombinant), Fc-VWF-XTEN Fusion Protein
- Antihemophilic Factor (recombinant), PEGylated
- Antithrombin alfa
- Antithrombin alfa
- Antithrombin III
- Antithrombin III
- Antithymocyte Globulin (Equine)
- Antivenin (Latrodectus mactans) (Equine)
- Apremilast (Systemic)
- Aprepitant/Fosaprepitant
- Articaine
- Asenapine
- Atracurium
- Atropine (EENT)
- Avacincaptad Pegol (EENT)
- Avacincaptad Pegol (EENT)
- Axicabtagene (Systemic)
- Clidinium
- Clindamycin (Systemic)
- Clonidine
- Clonidine (Epidural)
- Clonidine (Oral)
- Clonidine injection
- Clonidine transdermal
- Co-trimoxazole
- COVID-19 Vaccine (Janssen) (Systemic)
- COVID-19 Vaccine (Moderna)
- COVID-19 Vaccine (Pfizer-BioNTech)
- Crizanlizumab-tmca (Systemic)
- Cromolyn (EENT)
- Cromolyn (Systemic, Oral Inhalation)
- Crotalidae Polyvalent Immune Fab
- CycloSPORINE (EENT)
- CycloSPORINE (EENT)
- CycloSPORINE (Systemic)
- Cysteamine Bitartrate
- Cysteamine Hydrochloride
- Cysteamine Hydrochloride
- Cytomegalovirus Immune Globulin IV
- A1-Proteinase Inhibitor
- A1-Proteinase Inhibitor
- Bacitracin (EENT)
- Baloxavir
- Baloxavir
- Bazedoxifene
- Beclomethasone (EENT)
- Beclomethasone (Systemic, Oral Inhalation)
- Belladonna
- Belsomra
- Benralizumab (Systemic)
- Benzocaine (EENT)
- Bepotastine
- Betamethasone (Systemic)
- Betaxolol (EENT)
- Betaxolol (Systemic)
- Bexarotene (Systemic)
- Bismuth Salts
- Botulism Antitoxin (Equine)
- Brimonidine (EENT)
- Brivaracetam
- Brivaracetam
- Brolucizumab
- Brompheniramine
- Budesonide (EENT)
- Budesonide (Systemic, Oral Inhalation)
- Bulk-Forming Laxatives
- Bupivacaine (Local)
- BuPROPion (Systemic)
- Buspar
- Buspar Dividose
- Buspirone
- Butoconazole
- Cabotegravir (Systemic)
- Caffeine/Caffeine and Sodium Benzoate
- Calcitonin
- Calcium oxybate, magnesium oxybate, potassium oxybate, and sodium oxybate
- Calcium Salts
- Calcium, magnesium, potassium, and sodium oxybates
- Candida Albicans Skin Test Antigen
- Cantharidin (Topical)
- Capmatinib (Systemic)
- Carbachol
- Carbamide Peroxide
- Carbamide Peroxide
- Carmustine
- Castor Oil
- Catapres
- Catapres-TTS
- Catapres-TTS-1
- Catapres-TTS-2
- Catapres-TTS-3
- Ceftolozane/Tazobactam (Systemic)
- Cefuroxime
- Centruroides Immune F(ab′)2
- Cetirizine (EENT)
- Charcoal, Activated
- Chloramphenicol
- Chlorhexidine (EENT)
- Chlorhexidine (EENT)
- Cholera Vaccine Live Oral
- Choriogonadotropin Alfa
- Ciclesonide (EENT)
- Ciclesonide (Systemic, Oral Inhalation)
- Ciprofloxacin (EENT)
- Citrates
- Dacomitinib (Systemic)
- Dapsone (Systemic)
- Dapsone (Systemic)
- Daridorexant
- Darolutamide (Systemic)
- Dasatinib (Systemic)
- DAUNOrubicin and Cytarabine
- Dayvigo
- Dehydrated Alcohol
- Delafloxacin
- Delandistrogene Moxeparvovec (Systemic)
- Dengue Vaccine Live
- Dexamethasone (EENT)
- Dexamethasone (Systemic)
- Dexmedetomidine
- Dexmedetomidine
- Dexmedetomidine
- Dexmedetomidine (Intravenous)
- Dexmedetomidine (Oromucosal)
- Dexmedetomidine buccal/sublingual
- Dexmedetomidine injection
- Dextran 40
- Diclofenac (Systemic)
- Dihydroergotamine
- Dimethyl Fumarate (Systemic)
- Diphenoxylate
- Diphtheria and Tetanus Toxoids
- Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed
- Diroximel Fumarate (Systemic)
- Docusate Salts
- Donislecel-jujn (Systemic)
- Doravirine, Lamivudine, and Tenofovir Disoproxil
- Doxepin (Systemic)
- Doxercalciferol
- Doxycycline (EENT)
- Doxycycline (Systemic)
- Doxycycline (Systemic)
- Doxylamine
- Duraclon
- Duraclon injection
- Dyclonine
- Edaravone
- Edluar
- Efgartigimod Alfa (Systemic)
- Eflornithine
- Eflornithine
- Elexacaftor, Tezacaftor, And Ivacaftor
- Elranatamab (Systemic)
- Elvitegravir, Cobicistat, Emtricitabine, and tenofovir Disoproxil Fumarate
- Emicizumab-kxwh (Systemic)
- Emtricitabine and Tenofovir Disoproxil Fumarate
- Entrectinib (Systemic)
- EPINEPHrine (EENT)
- EPINEPHrine (Systemic)
- Erythromycin (EENT)
- Erythromycin (Systemic)
- Estrogen-Progestin Combinations
- Estrogen-Progestin Combinations
- Estrogens, Conjugated
- Estropipate; Estrogens, Esterified
- Eszopiclone
- Ethchlorvynol
- Etranacogene Dezaparvovec
- Evinacumab (Systemic)
- Evinacumab (Systemic)
- Factor IX (Human), Factor IX Complex (Human)
- Factor IX (Recombinant)
- Factor IX (Recombinant), albumin fusion protein
- Factor IX (Recombinant), Fc fusion protein
- Factor VIIa (Recombinant)
- Factor Xa (recombinant), Inactivated-zhzo
- Factor Xa (recombinant), Inactivated-zhzo
- Factor XIII A-Subunit (Recombinant)
- Faricimab
- Fecal microbiota, live
- Fedratinib (Systemic)
- Fenofibric Acid/Fenofibrate
- Fibrinogen (Human)
- Flunisolide (EENT)
- Fluocinolone (EENT)
- Fluorides
- Fluorouracil (Systemic)
- Flurbiprofen (EENT)
- Flurbiprofen (EENT)
- Flurbiprofen (EENT)
- Flurbiprofen (EENT)
- Fluticasone (EENT)
- Fluticasone (Systemic, Oral Inhalation)
- Fluticasone and Vilanterol (Oral Inhalation)
- Ganciclovir Sodium
- Gatifloxacin (EENT)
- Gentamicin (EENT)
- Gentamicin (Systemic)
- Gilteritinib (Systemic)
- Glofitamab
- Glycopyrronium
- Glycopyrronium
- Gonadotropin, Chorionic
- Goserelin
- Guanabenz
- Guanadrel
- Guanethidine
- Guanfacine
- Haemophilus b Vaccine
- Hepatitis A Virus Vaccine Inactivated
- Hepatitis B Vaccine Recombinant
- Hetlioz
- Hetlioz LQ
- Homatropine
- Hydrocortisone (EENT)
- Hydrocortisone (Systemic)
- Hydroquinone
- Hylorel
- Hyperosmotic Laxatives
- Ibandronate
- Igalmi buccal/sublingual
- Imipenem, Cilastatin Sodium, and Relebactam
- Inclisiran (Systemic)
- Infliximab, Infliximab-dyyb
- Influenza Vaccine Live Intranasal
- Influenza Vaccine Recombinant
- Influenza Virus Vaccine Inactivated
- Inotuzumab
- Insulin Human
- Interferon Alfa
- Interferon Beta
- Interferon Gamma
- Intermezzo
- Intuniv
- Iodoquinol (Topical)
- Iodoquinol (Topical)
- Ipratropium (EENT)
- Ipratropium (EENT)
- Ipratropium (Systemic, Oral Inhalation)
- Ismelin
- Isoproterenol
- Ivermectin (Systemic)
- Ivermectin (Topical)
- Ixazomib Citrate (Systemic)
- Japanese Encephalitis Vaccine
- Kapvay
- Ketoconazole (Systemic)
- Ketorolac (EENT)
- Ketorolac (EENT)
- Ketorolac (EENT)
- Ketorolac (EENT)
- Ketorolac (Systemic)
- Ketotifen
- Lanthanum
- Lecanemab
- Lefamulin
- Lemborexant
- Lenacapavir (Systemic)
- Leniolisib
- Letermovir
- Letermovir
- Levodopa/Carbidopa
- LevoFLOXacin (EENT)
- LevoFLOXacin (Systemic)
- L-Glutamine
- Lidocaine (Local)
- Lidocaine (Systemic)
- Linezolid
- Lofexidine
- Loncastuximab
- Lotilaner (EENT)
- Lotilaner (EENT)
- Lucemyra
- Lumasiran Sodium
- Lumryz
- Lunesta
- Mannitol
- Mannitol
- Mb-Tab
- Measles, Mumps, and Rubella Vaccine
- Mecamylamine
- Mechlorethamine
- Mechlorethamine
- Melphalan (Systemic)
- Meningococcal Groups A, C, Y, and W-135 Vaccine
- Meprobamate
- Methoxy Polyethylene Glycol-epoetin Beta (Systemic)
- Methyldopa
- Methylergonovine, Ergonovine
- MetroNIDAZOLE (Systemic)
- MetroNIDAZOLE (Systemic)
- Miltown
- Minipress
- Minocycline (EENT)
- Minocycline (Systemic)
- Minoxidil (Systemic)
- Mometasone
- Mometasone (EENT)
- Moxifloxacin (EENT)
- Moxifloxacin (Systemic)
- Nalmefene
- Naloxone (Systemic)
- Natrol Melatonin + 5-HTP
- Nebivolol Hydrochloride
- Neomycin (EENT)
- Neomycin (Systemic)
- Netarsudil Mesylate
- Nexiclon XR
- Nicotine
- Nicotine
- Nicotine
- Nilotinib (Systemic)
- Nirmatrelvir
- Nirmatrelvir
- Nitroglycerin (Systemic)
- Ofloxacin (EENT)
- Ofloxacin (Systemic)
- Oliceridine Fumarate
- Olipudase Alfa-rpcp (Systemic)
- Olopatadine
- Omadacycline (Systemic)
- Osimertinib (Systemic)
- Oxacillin
- Oxymetazoline
- Pacritinib (Systemic)
- Palovarotene (Systemic)
- Paraldehyde
- Peginterferon Alfa
- Peginterferon Beta-1a (Systemic)
- Penicillin G
- Pentobarbital
- Pentosan
- Pilocarpine Hydrochloride
- Pilocarpine, Pilocarpine Hydrochloride, Pilocarpine Nitrate
- Placidyl
- Plasma Protein Fraction
- Plasminogen, Human-tmvh
- Pneumococcal Vaccine
- Polymyxin B (EENT)
- Polymyxin B (Systemic, Topical)
- PONATinib (Systemic)
- Poractant Alfa
- Posaconazole
- Potassium Supplements
- Pozelimab (Systemic)
- Pramoxine
- Prazosin
- Precedex
- Precedex injection
- PrednisoLONE (EENT)
- PrednisoLONE (Systemic)
- Progestins
- Propylhexedrine
- Protamine
- Protein C Concentrate
- Protein C Concentrate
- Prothrombin Complex Concentrate
- Pyrethrins with Piperonyl Butoxide
- Quviviq
- Ramelteon
- Relugolix, Estradiol, and Norethindrone Acetate
- Remdesivir (Systemic)
- Respiratory Syncytial Virus Vaccine, Adjuvanted (Systemic)
- RifAXIMin (Systemic)
- Roflumilast (Systemic)
- Roflumilast (Topical)
- Roflumilast (Topical)
- Rotavirus Vaccine Live Oral
- Rozanolixizumab (Systemic)
- Rozerem
- Ruxolitinib (Systemic)
- Saline Laxatives
- Selenious Acid
- Selexipag
- Selexipag
- Selpercatinib (Systemic)
- Sirolimus (Systemic)
- Sirolimus, albumin-bound
- Smallpox and Mpox Vaccine Live
- Smallpox Vaccine Live
- Sodium Chloride
- Sodium Ferric Gluconate
- Sodium Nitrite
- Sodium oxybate
- Sodium Phenylacetate and Sodium Benzoate
- Sodium Thiosulfate (Antidote) (Systemic)
- Sodium Thiosulfate (Protectant) (Systemic)
- Somatrogon (Systemic)
- Sonata
- Sotorasib (Systemic)
- Suvorexant
- Tacrolimus (Systemic)
- Tafenoquine (Arakoda)
- Tafenoquine (Krintafel)
- Talquetamab (Systemic)
- Tasimelteon
- Tedizolid
- Telotristat
- Tenex
- Terbinafine (Systemic)
- Tetrahydrozoline
- Tezacaftor and Ivacaftor
- Theophyllines
- Thrombin
- Thrombin Alfa (Recombinant) (Topical)
- Timolol (EENT)
- Timolol (Systemic)
- Tixagevimab and Cilgavimab
- Tobramycin (EENT)
- Tobramycin (Systemic)
- TraMADol (Systemic)
- Trametinib Dimethyl Sulfoxide
- Trancot
- Tremelimumab
- Tretinoin (Systemic)
- Triamcinolone (EENT)
- Triamcinolone (Systemic)
- Trimethobenzamide
- Tucatinib (Systemic)
- Unisom
- Vaccinia Immune Globulin IV
- Valoctocogene Roxaparvovec
- Valproate/Divalproex
- Valproate/Divalproex
- Vanspar
- Varenicline (Systemic)
- Varenicline (Systemic)
- Varenicline Tartrate (EENT)
- Vecamyl
- Vitamin B12
- Vonoprazan, Clarithromycin, and Amoxicillin
- Wytensin
- Xyrem
- Xywav
- Zaleplon
- Zirconium Cyclosilicate
- Zolpidem
- Zolpidem (Oral)
- Zolpidem (Oromucosal, Sublingual)
- ZolpiMist
- Zoster Vaccine Recombinant
- 5-hydroxytryptophan, melatonin, and pyridoxine
Carane nggunakake Potassium Supplements
Administrasi
Kanggo oral utawa kanthi infus IV alon. Injeksi sing ngandhut kalium (biasane kalium klorida), wis ditindakake kanthi hypodermoclysis† [off-label] (menyang jaringan subkutan).
Kalium asetat, bikarbonat, klorida, sitrat, lan glukonat bisa ditindakake kanthi lisan. Kalium asetat lan klorida bisa diwènèhaké IV.
Yen bisa, suplemen kalium kudu diwènèhaké kanthi lisan amarga panyerepan sing relatif alon saka saluran GI nyegah paningkatan konsentrasi kalium plasma sing tiba-tiba. Ganti terapi kalium IV kanthi suplemen oral lan/utawa ngonsumsi panganan sing sugih kalium sanalika bisa.
Administrasi Oral
Suplemen kalium oral kudu diwenehake kanthi utawa sawise mangan kanthi segelas banyu utawa jus woh kanggo nyilikake kemungkinan iritasi GI lan efek katartik saline.
Biasane diwenehake kanthi lisan ing 1-4 dosis saben dina. Dosis saben dina> 20 mEq kudu dipérang dadi sawetara dosis lan ora bisa diwènèhaké minangka dosis siji.
Bubuk utawa tablet kanggo solusi lisan kudu dibubarake lan/utawa diencerake lan diwenehake miturut pandhuane pabrikan.
Persediaan kalium klorida sing dibebasake kanthi lengkap kudu dilindhungi kanggo digunakake ing pasien sing ora bisa ngidinke utawa nolak njupuk persiapan kalium cair utawa effervescent utawa kanggo wong-wong sing ana masalah kepatuhan karo bentuk dosis sing terakhir.
Infus IV
Pemantauan ECG lan konsentrasi kalium plasma sing cetha penting sajrone administrasi IV kalium, utamane nalika tingkat administrasi > 20 mEq / jam. (Deleng Hiperkalemia ing Caution.)
Solusi kalium IV umume kudu diwenehake mung ing pasien kanthi aliran urin sing cukup (contone, diwenehake kanggo pasien pasca operasi mung sawise aliran urin sing cukup).
Ing pasien dehidrasi, 1 liter cairan bebas kalium kudu diwenehake sadurunge miwiti terapi kalium.
Intoleransi vaskular lokal bisa mbatesi kemampuan kanggo ngatur solusi pekat; ngatur liwat vena gedhe, aliran dhuwur (umpamane, vena femoral) utawa ngatur solusi sing kurang konsentrasi ing dosis sing dibagi liwat 2 vena bebarengan. Ngindhari administrasi larutan kalium pekat liwat kateter atrium suBClavian, jugular, utawa tengen; Konsentrasi kalium lokal sing diraih ing jantung bisa uga dhuwur lan duweni potensi kardiotoksik.
Injeksi kalium klorida ing wadhah plastik ora kena digunakake ing sambungan seri karo wadhah plastik liyane, amarga panggunaan kasebut bisa nyebabake embolisme udara saka sisa udara. dijupuk saka wadhah utama sadurunge administrasi cairan saka wadhah sekunder rampung.
Hiperkalemia wis dilapurake nalika larutan kalium klorida pekat ditambahake ing infus IV saka wadhah plastik fleksibel sing digantung, katon minangka akibat saka pooling saka solusi kalium klempakan ing dasar wadhah lan infus saka solusi undiluted. Ngemot wadhah ora nggampangake nyampur nanging cenderung ngompa solusi sing konsentrasi menyang kamar infus. Solusi kasebut kudu dicampur kanthi ati-ati kanthi ngowahi wadhah plastik sajrone nambahake larutan kalium kanthi agitasi lan/utawa kneading sabanjure kanggo nyegah pooling.
PengenceranKanggo informasi kompatibilitas solusi lan obat, deleng Kompatibilitas ing Stabilitas.
p>Kalium asetat lan kalium klorida kasedhiya minangka konsentrat sing kudu diencerake sadurunge administrasi IV.
Umume, konsentrasi kalium ing cairan IV ora kudu ngluwihi 40 mEq/L. Nanging, konsentrasi kalium sing luwih dhuwur (contone, 60–80 mEq/L) kadhangkala bisa uga dibutuhake kanggo perawatan hipokalemia abot lan aritmia jantung sing gegandhengan, ketoacidosis diabetes utawa fase diuretik gagal ginjal akut.
Tingkat AdministrasiKudu ditindakake kanthi infus IV alon. Umume, tingkat administrasi ngirim ora ngluwihi 20 mEq / jam.
Kadhangkala administrasi sing luwih cepet bisa uga dibutuhake kanggo perawatan hipokalemia abot lan aritmia jantung sing gegandhengan utawa ketoacidosis diabetes utawa fase diuretik gagal ginjal akut.
Hypodermoclysis
Yen diwenehake dening hypodermoclysis† [off-label], konsentrasi kalium ngirim ora ngluwihi 10 mEq/L kanggo nyegah nyeri lokal.
Dosis
Dosis suplemen kalium biasane ditulis minangka mEq kalium.
Kebutuhan kalium saben dina wong diwasa normal lan asupan kalium ing diet biasa yaiku 40–80 mEq; bayi mbutuhake 2-3 mEq / kg utawa 40 mEq / m2 saben dina.
Dosis kudu kasebut kanthi teliti, individualized miturut syarat lan respon sabar.
Kanggo nyegah hiperkalemia serius, panggantos defisit kalium kudu ditindakake kanthi bertahap, biasane sajrone wektu 3 nganti 7 dina gumantung saka keruwetan defisit.
Persyaratan penggantian kalium bisa ditindakake. ditaksir mung kanthi kondisi klinis lan respon, pemantauan ECG, lan/utawa penentuan kalium plasma.
Setara Dosis Garam Kalium Oral40 mEq kalium diwenehake kira-kira:
3.9 g kalium asetat
4,0 g kalium bikarbonat
3,0 g kalium klorida
4,3 g kalium sitrat
9,4 g kalium glukonat
Pasien Anak
Hipokalemia† [off-label] Pencegahan utawa Perawatan† [off-label] OralYen digunakake ing pasien pediatrik†, ora ngluwihi 3 mEq/kg saben dina ing bocah cilik.
Dewasa
Nyegah Hipokalemia OralDosis rata-rata kira-kira 20 mEq saben dina. Biasane ngirim ora ngluwihi 200 mEq saben dina.
Perawatan OralDosis biasa yaiku 40-100 mEq utawa luwih saben dina. Biasane ngirim ora ngluwihi 200 mEq saben dina.
Batesan Resep
Pasien Anak
Hipokalemia† Nyegah utawa Perawatan† Oral3 mEq/kg saben dina kanggo bocah cilik.
Dewasa< /h4> Nyegah utawa Perawatan Hipokalemia Oral
Biasane ora ngluwihi 200 mEq saben dina.
Populasi Khusus
Gangguan Ginjal
Pamilihan dosis sing ati-ati lan ngawasi kanthi ati-ati dianjurake kanggo pasien sing duwe gangguan ginjel.
Pasien Geriatri
Pilih dosis kanthi ati-ati, diwiwiti saka sawetara dosis sing sithik, amarga nyuda fungsi ati, ginjel, lan/utawa jantung sing gegandhengan karo umur lan penyakit bebarengan lan terapi obat.
Pènget
Kontraindikasi
Pènget/PanandhapPènget
Hiperkalemia
Hiperkalemia lan serangan jantung bisa kedadeyan sawise nggunakake suplemen kalium ing pasien sing duwe gangguan mekanisme kanggo ngekskresi kalium. Efek samping sing paling umum lan serius saka terapi kalium.
Berpotensi fatal; bisa berkembang kanthi cepet lan pasien bisa uga asimtomatik. Paling asring kedadeyan karo kalium IV (utamane yen diwenehake kanthi cepet), nanging bisa uga kedadeyan karo kalium oral.
Gunakake solusi IV sing ngemot kalium kanthi ati-ati banget, yen ana, ing pasien hiperkalemia, gagal ginjel abot, utawa kahanan liyane kanthi retensi kalium.
Evaluasi fungsi ginjel sadurunge terapi; ngawasi status klinis kanthi ECGs periodik lan/utawa nemtokake konsentrasi kalium plasma.
Tandha klinis lan gejala hiperkalemia kalebu paresthesia saka ekstremitas, lemes, kebingungan mental, kekirangan utawa abot ing sikil, lumpuh flaksid, kadhemen. kulit, pucat abu-abu, ambruk pembuluh darah perifer kanthi tekanan getih mudhun, aritmia jantung, lan blok jantung.
Asidosis MetabolikIng pasien sing nandhang hipokalemia lan asidosis metabolik, uyah kalium alkalinisasi (asetat, bikarbonat, sitrat). glukonat) kudu digunakake kanggo perawatan hipokalemia.
Kakehan Cairan lan Negara EdemaPanganggone solusi IV sing ngandhut kalium bisa nyebabake kakehan cairan lan/utawa solute, sing nyebabake konsentrasi elektrolit mudhun, overhidrasi, kongesti, lan edema paru.
Gunakake IV solusi sing ngemot kalium kanthi ati-ati banget, yen kabeh, ing pasien karo CHF, insufisiensi ginjel sing abot, utawa kondisi liyane kanthi retensi natrium lan edema.
Lesi GIDosis kalium oral sing padhet wis nyebabake ulcerative lan/ utawa lesi GI stenotik; perforasi wis kedadeyan. Bisa uga luwih kerep nganggo tablet sing dilapisi enterik (ora kasedhiya kanggo komersial maneh ing AS).
Ngatur matriks lilin lan preparat sing diluncurake kanthi lengkap kanthi ati-ati; langsung mandheg yen weteng lara, distensi, mutahke abot, utawa getihen GI ana.
Reserve nggunakake preparat kalium klorida sing dibebasake sing diperluas kanggo pasien sing ora bisa ngidinke utawa nolak kanggo njupuk preparat kalium cair utawa effervescent utawa kanggo sing ana sing ana masalah kepatuhan karo bentuk dosis sing terakhir.
Sawetara ahli takon babagan panggunaan persiapan kalium sing padhet, amarga nggunakake preparat cair sing encer nyuda risiko komplikasi GI.
Reaksi LokalNyeri lan flebitis bisa kedadeyan ing situs administrasi IV, utamane karo larutan kalium sing ngemot ≥30 mEq/L.
Pancegahan Umum
Pemantauan LaboratoriumPantau keseimbangan cairan, konsentrasi elektrolit, lan keseimbangan asam-basa kanthi periodik sajrone terapi. Penentuan kalium serum kanthi reguler dianjurake, utamane ing pasien kanthi gangguan ginjel utawa nefropati diabetes.
Panganggone Solusi ParenteralNalika kalium diwenehake IV ing larutan parenteral, nimbang ati-ati, pancegahan, lan kontraindikasi sing ana gandhengane karo volume cairan lan elektrolit sing ana ing cairan infus IV.
Populasi Spesifik
KandhutanKategori C.
LaktasiOra dingerteni manawa kalium disebarake menyang susu. Gunakake kanthi ati-ati.
Panggunaan PediatrikKaamanan lan khasiat durung ditetepake.
Panggunaan GeriatrikTanggepan ing pasien ≥65 taun ora katon beda karo wong diwasa sing luwih enom; Nanging, gunakake kanthi ati-ati amarga frekuensi sing luwih akeh nyuda fungsi ati, ginjel, lan/utawa jantung lan penyakit bebarengan lan terapi obat sing diamati ing wong tuwa.
Monitor fungsi ginjel.
Gagal GinjalLarutan parenteral sing ngandhut kalium bisa nyebabake retensi natrium lan/utawa kalium.
Gunakake kanthi ati-ati; ngawasi konsentrasi kalium plasma kanthi kerep.
Efek Samsaya Awon
Hiperkalemia; Efek GI (mual, muntah, diare, kembung, nyeri weteng utawa rasa ora nyaman); reaksi situs infus.
Apa obatan liyane bakal mengaruhi Potassium Supplements
Obat Spesifik
Obat
Interaksi
Komentar
Inhibitor ACE (contone, kaptopril, enalapril)
Tambah risiko hiperkalemia
Gunakake bebarengan mung yen diawasi rapet; ngawasi kalium serum kanthi kerep
Kortikosteroid
Ngati-ati nalika digunakake bebarengan karo solusi parenteral sing ngandhut kalium
Corticotropin (ACTH)
Ngati-ati nalika digunakake bebarengan karo solusi parenteral sing ngandhut kalium
Diuretik, kalium-sparing (contone, amilorida, spironolactone, triamterene)
Tambah risiko hiperkalemia abot
Kontraindikasi panggunaan bebarengan

Disclaimer
Kabeh upaya wis ditindakake kanggo mesthekake yen informasi sing diwenehake dening Drugslib.com akurat, nganti -tanggal, lan lengkap, nanging ora njamin kanggo efek sing. Informasi obat sing ana ing kene bisa uga sensitif wektu. Informasi Drugslib.com wis diklumpukake kanggo digunakake dening praktisi kesehatan lan konsumen ing Amerika Serikat lan mulane Drugslib.com ora njamin sing nggunakake njaba Amerika Serikat cocok, kajaba khusus dituduhake digunakake. Informasi obat Drugslib.com ora nyetujoni obat, diagnosa pasien utawa menehi rekomendasi terapi. Informasi obat Drugslib.com minangka sumber informasi sing dirancang kanggo mbantu praktisi kesehatan sing dilisensi kanggo ngrawat pasien lan / utawa nglayani konsumen sing ndeleng layanan iki minangka tambahan, lan dudu pengganti, keahlian, katrampilan, kawruh lan pertimbangan babagan perawatan kesehatan. praktisi.
Ora ana bebaya kanggo kombinasi obat utawa obat sing diwenehake kanthi cara apa wae kudu ditafsirake kanggo nuduhake yen obat utawa kombinasi obat kasebut aman, efektif utawa cocok kanggo pasien tartamtu. Drugslib.com ora nanggung tanggung jawab kanggo aspek kesehatan apa wae sing ditindakake kanthi bantuan informasi sing diwenehake Drugslib.com. Informasi sing ana ing kene ora dimaksudake kanggo nyakup kabeh panggunaan, pituduh, pancegahan, bebaya, interaksi obat, reaksi alergi, utawa efek samping. Yen sampeyan duwe pitakon babagan obat sing sampeyan gunakake, takon dhokter, perawat utawa apoteker.
Kata kunci populer
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions